Ketorolac Trometamine Injection
- Packing: 1 Ml Ampoule.
- Available Strength : 30 Mg/Ml
Description
Product Description: Ketorolac Trometamine Injection is a meticulously formulated pharmaceutical solution designed to provide potent analgesia and anti-inflammatory effects. It contains ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID) known for its rapid onset of action and efficacy in managing moderate to severe pain. Manufactured to the highest quality standards, this injection is trusted by healthcare professionals for its reliability and effectiveness in pain management.
Indications and Usage: Ketorolac Trometamine Injection is indicated for the short-term (up to 5 days) management of moderate to severe pain, such as that following surgery or traumatic injury, where analgesia is required at the opioid level. It is particularly useful in situations where oral administration is not feasible or desirable.
Dosage and Administration: The dosage of Ketorolac Trometamine Injection varies depending on the patient's age, weight, and the severity of pain. It is typically administered via intramuscular or slow intravenous route under the supervision of a qualified healthcare professional. Dosage adjustments may be necessary based on the patient's response to therapy and individual tolerance.
Dosage Forms and Strengths: Ketorolac Trometamine Injection is available as a sterile solution in vials containing specific concentrations of ketorolac tromethamine formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to ketorolac or any of the excipients. It should not be used in patients with a history of asthma, urticaria, or other allergic reactions to NSAIDs. Additionally, it is contraindicated in patients with active peptic ulcer disease or gastrointestinal bleeding, cerebrovascular bleeding, or bleeding disorders.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Ketorolac Trometamine Injection to patients with a history of cardiovascular diseases, renal impairment, or hepatic dysfunction. Prolonged use may increase the risk of gastrointestinal bleeding, renal toxicity, and cardiovascular events. Patients should be monitored closely for signs of these adverse effects during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Ketorolac Trometamine Injection include gastrointestinal disturbances such as nausea, dyspepsia, and abdominal pain. Rarely, serious adverse effects such as gastrointestinal ulceration, renal failure, and cardiovascular events may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Ketorolac Trometamine Injection with other NSAIDs, anticoagulants, or antiplatelet agents may increase the risk of gastrointestinal bleeding or alter the pharmacokinetics of ketorolac. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Ketorolac Trometamine Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Ketorolac Trometamine Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
